Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity

por Tawfik, Haytham O., Shaldam, Moataz A., Nocentini, Alessio, Salem, Rofaida, Almahli, Hadia, Al-Rashood, Sara T., Supuran, Claudiu T., Eldehna, Wagdy M.
Publicado 2022

Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors

por Shaldam, Moataz, Nocentini, Alessio, Elsayed, Zainab M., Ibrahim, Tamer M., Salem, Rofaida, El-Domany, Ramadan A., Capasso, Clemente, Supuran, Claudiu T., Eldehna, Wagdy M.
Publicado 2021

Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer

por Eldehna, Wagdy M., Salem, Rofaida, Elsayed, Zainab M., Al-Warhi, Tarfah, Knany, Hamada R., Ayyad, Rezk R., Traiki, Thamer Bin, Abdulla, Maha-Hamadien, Ahmad, Rehan, Abdel-Aziz, Hatem A., El-Haggar, Radwan
Publicado 2021

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors

por Shaldam, Moataz A., Almahli, Hadia, Angeli, Andrea, Badi, Rehab Mustafa, Khaleel, Eman F., Zain-Alabdeen, Abdelrahman I., Elsayed, Zainab M., Elkaeed, Eslam B., Salem, Rofaida, Supuran, Claudiu T., Eldehna, Wagdy M., Tawfik, Haytham O.
Publicado 2023